Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 20.01 Delayed Data As of Jan 17 |  -0.05 / -0.25%Today’s Change | 16.10 Today|||52-Week Range 21.61 | +1.42% Year-to-Date |
Latest TAK News | Press Releases
No recent news for Takeda Pharmaceutical Co Ltd.
Today’s Trading
| Previous close | 20.06 |
| Today’s open | 20.07 |
| Day’s range | 19.96 - 20.12 |
| Volume | 944,154 |
| Average volume (3 months) | 1,223,085 |
| Market cap | $62.4B |
Data as of 6:30pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | -52.61% |
| Earnings growth (this year) | -206.37% |
| Earnings growth (next 5 years) | +16.80% |
| Revenue growth (last year) | +18.39% |
| P/E ratio | NM |
| Price/Sales | 2.08 |
| Price/Book | 1.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AGNAllergan | -1.15 | -0.59% |
| VRTXVertex Pharmaceutica... | +0.33 | +0.14% |
| ZTSZoetis Inc | +0.92 | +0.66% |
| ---- |
Data as of 6:30pm ET, 01/17/2020
Financials
| Next reporting date | January 29, 2020 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $18.9B |
| Annual profit (last year) | $984.1M |
| Net profit margin | 5.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
